Roshanak Semnani

Roshanak Semnani currently serves as Executive Director and Senior Director of Autoimmunity and Translational Immunology at Precigen, a biopharmaceutical company focused on innovative gene and cell therapies for serious diseases. Prior experience includes a tenure at the National Institutes of Health (NIH) as a Senior Staff Scientist and Staff Scientist from 2004 to September 2018. Roshanak Semnani holds a Ph.D. in Immunology from the University of Chicago and a B.S. in Genetics from the University of California, Berkeley.